GlassScriptPhysician profile
David T Vonk
NPI 1194988204
$5,615.04
in general payments reported to CMS, 2019-2025
52 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what 87% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $247 · 2022: $305 · 2023: $1,522 · 2024: $1,844 · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,823 · Education: $15.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,823.36 |
| Education | $15.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $654.95 | 2020-2025 | Imfinzi, Lynparza, Enhertu |
| Novartis Pharmaceuticals Corporation | $613.57 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $431.76 | 2019-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $317.32 | 2023-2025 | Tecvayli, Darzalex, Carvykti |
| Amgen INC. | $231.76 | 2019-2023 | Kyprolis, Lumakras |
| Takeda Pharmaceuticals U.S.A., INC. | $214.53 | 2020-2025 | Alunbrig, Ninlaro, Fruzaqla |
| Pfizer INC. | $209.00 | 2023-2025 | |
| Daiichi Sankyo INC. | $175.96 | 2024-2025 | Enhertu, Injectafer |
| Seagen INC. | $175.57 | 2020-2023 | Tukysa, Adcetris, Padcev |
| Abbvie INC. | $159.74 | 2020-2025 | Venclexta |
| Genzyme Corporation | $151.06 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.98 | 2020-2025 | |
| Pharmacosmos Therapeutics INC. | $130.04 | 2022-2025 | Monoferric |
| Incyte Corporation | $126.24 | 2020-2025 | Jakafi, Monjuvi |
| Sumitomo Pharma America, INC. | $124.57 | 2023-2025 | Orgovyx |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $117.13 | 2023-2024 | Brukinsa |
| Lilly USA, LLC | $111.16 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Regeneron Healthcare Solutions, INC. | $107.38 | 2024 | Libtayo |
| Stemline Therapeutics INC. | $104.96 | 2023-2024 | Orserdu |
| Jazz Pharmaceuticals INC. | $93.03 | 2020-2025 | |
| Rigel Pharmaceuticals, INC. | $78.45 | 2024-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Genmab U.S., INC. | $76.68 | 2023-2024 | Epkinly, Tivdak |
| Emd Serono, INC. | $70.08 | 2022-2025 | Bavencio |
| Glaxosmithkline, LLC. | $69.63 | 2024-2025 | Ojjaara |
| Deciphera Pharmaceuticals INC. | $64.12 | 2023-2024 | Qinlock |
| Recordati_rare_diseases_inc. | $63.73 | 2023-2025 | Sylvant, Enjaymo |
| Ipsen Biopharmaceuticals, INC | $60.76 | 2022-2024 | Onivyde, Somatuline Depot |
| Caris Mpi, INC. | $59.24 | 2025 | Mi Cancer Seek |
| Adaptive Biotechnologies Corporation | $55.23 | 2024-2025 | Clonoseq |
| Sun Pharmaceutical Industries INC. | $54.76 | 2023-2024 | Odomzo, Yonsa |
| Tempus Ai, INC | $50.09 | 2024 | Xt Cdx |
| Karyopharm Therapeutics INC. | $47.72 | 2023-2025 | Xpovio |
| Genentech USA, INC. | $43.63 | 2024-2025 | Phesgo, Polivy |
| Tersera Therapeutics LLC | $36.23 | 2023 | Zoladex |
| Sobi, INC | $34.31 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $32.73 | 2023 | Ultomiris |
| Celgene Corporation | $29.16 | 2022 | |
| Morphosys, US INC. | $27.98 | 2023 | Monjuvi |
| Puma Biotechnology, INC. | $25.15 | 2024 | |
| Astellas Pharma US INC | $23.85 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $23.68 | 2020 | |
| Menarini Silicon Biosystems, INC. | $23.34 | 2025 | |
| Amneal Pharmaceuticals LLC | $23.03 | 2024 | Neupogen, Avastin, Neulasta |
| Aveo Pharmaceuticals, INC. | $20.97 | 2023 | Fotivda |
| Coherus Oncology, INC. | $18.42 | 2023 | |
| Azurity Pharmaceuticals, INC. | $17.98 | 2025 | Danziten |
| Progenics Pharmaceuticals, INC. | $17.83 | 2024 | |
| Tactile Systems Technology INC | $17.12 | 2023 | Flexitouch Plus, Entre Plus |
| Teleflex LLC | $15.65 | 2025 | Barrigel |
| Shire North American Group INC | $15.38 | 2019 | |
| Verity Pharmaceuticals INC. | $13.23 | 2022 | |
| Secura Bio, INC. | $13.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Vonk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.